Dermal Lesions and Skin Cancer in Patients with Inflammatory Bowel Disease Receiving Immunosuppressive Therapy

BACKGROUND: Anti-TNFa medications represent the first effective biologic therapy for IBD that has largely revolutionized treatment. The aim of this study was to quantify the risk of MM and other skin cancers among patients from Northern Greece area with IBD who take immunosuppressive or biologic ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Giagkou, Eftychia, Saridi, Maria, Albani, Eleni, Gaitanis, Georgios, Katsanos, Andreas, Bechlioulis, Aris, Bacasis, Athanasios-Dimitrios, Christodoulou, Dimitrios K, Katsanos, Konstantinos H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291021/
https://www.ncbi.nlm.nih.gov/pubmed/30362311
http://dx.doi.org/10.22034/APJCP.2018.19.10.2845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291021/
https://www.ncbi.nlm.nih.gov/pubmed/30362311
http://dx.doi.org/10.22034/APJCP.2018.19.10.2845

Ejemplares similares